🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Incidence of Peri-implant Mucositis in Patients With Treated Periodontitis

Recruitingn/aAges 18 Years - anyAllUniversidad Complutense de Madrid
NCT05356806 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

the objective of this study is to determine the incidence of peri-implant mucositis in patients with treated periodontitis and enrolled in periodontal maintenance and to evaluate the associated risk indicators. An analytical prospective observational study will be carried out, with an initial follow-up of 12 months.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Over 18 years of age, able to comply with the protocol and comply with the established visits. * Patients with treated periodontitis and enrolled in periodontal maintenance (last maintenance therapy received between 4 and 6 months maximum before inclusion in the study) (Chapple et al., 2018, Sanz et al., 2020). * Patients with osseointegrated dental implants waiting for their prosthodontic rehabilitation (fixed prosthesis \[individual, partial or complete\], hybrid or overdenture). * Physical or mental conditions that make it possible to perform appropiate oral hygiene Exclusion Criteria: * Patients with untreated periodontitis. * Totally edentulous patients. * Patients with peri-implant diseases. * Pregnant or in lactating-period patients. * Patients undergoing treatment with medication that affects the periodontal/peri-implant status or the immune system (phenytoin, calcium antagonists, corticosteroids or anti-inflammatories). * Patients who have taken antibiotics in the last month.
💊

What it tests

  • Supportive periodontal and periimplant care
📍

Where

1 site
Faculty of Dentistry, University Complutense of Madrid (UCM)
Madrid, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy